LEDERDOPA |
MK-351 |
METALPHA 500 |
DOPAMET |
MEDOMET |
METHYLDOPA HYDRATE |
BAYER-1440L |
METALPHA 250 |
ALDOMET |
J9.247I |
NSC-169916 |
METHYLDOPA |
ALPHA-METHYLDOPA |
METHYLDOPA (LEVOROTATORY) |
METHYLDOPA SESQUIHYDRATE |
NOVOMEDOPA |
SEMBRINA |
METHYL DOPA |
METHOPLAIN |
DOPEGYT |
L-(-)-3-(3,4-DIHYDROXYPHENYL)-2-METHYL-ALANINE |
L-3-(3,4-DIHYDROXYPHENYL)-2-METHYLALANINE |
ALDORIL D30 |
NU-MEDOPA TAB 250MG |
PRESOLISIN |
METHYLDOPA 500 TAB 500MG |
NU-MEDOPA |
NOVO-MEDOPA TAB 500MG |
L(-)-ALPHA-METHYLALANINE |
ALPHA-METHYLDOPA (VAN) |
BECANTA |
(S)-(-)-ALPHA-METHYLDOPA |
MEDOPA |
METHYLDOPA ANHYDROUS |
NOVO-MEDOPA TAB 125MG |
2-METHYL-3-(3,4-DIHYDROXYPHENYL)ALANINE |
A-METHYL-L-DOPA |
APO METHYLDOPA TAB 125MG |
(-)-A-METHYLDOPA |
METHYLDOPA 125 TAB 125MG |
NU-MEDOPA TAB 125MG |
L-ALPHA-METHYLDOPA |
ALPHA-METHYL-L-DOPA |
ALDORIL 25 |
AMD |
(-)-ALPHA-METHYLDOPA |
(-)-METHYLDOPA |
L-2-AMINO-2-METHYL-3-(3,4-DIHYDROXYPHENYL)PROPIONIC ACID |
Α-METHYL DOPA |
APO METHYLDOPA TAB 500MG |
ALDORIL 15 |
APO METHYLDOPA TAB 250MG |
BAYER 1440 L |
3-HYDROXY-ALPHA-METHYL-L-TYROSINE |
DOPAMETHYPERPAX |
L-A-METHYLDOPA |
(S)-(-)-A-METHYLDOPA |
ALPHA-METHYL-L-3,4-DIHYDROXYPHENYLALANINE |
(2S)-2-AMINO-3-(3,4-DIHYDROXYPHENYL)-2-METHYLPROPANOIC ACID |
MEDOPAL |
A-METHYLDOPA (VAN) |
METHYLDOPATE HCL |
ALDOCLOR-150 |
SEDOMETIL |
ALPHAMETHYLDOPA |
ALDOCLOR-250 |
L-(-)-ALPHA-METHYL-BETA-(3,4-DIHYDROXYPHENYL)ALANINE |
MEDOPREN |
L-(-)-3-(3,4-DIHYDROXYPHENYL)-2-METHYLALANINE |
METHYL-L-DOPA |
L(-)-A-METHYLALANINE |
GROSPISK |
HYPOLAG |
METHYLDOPATE |
L-METHYL DOPA |
ALDORIL® |
NU-MEDOPA TAB 500MG |
ALPHA-METHYL DOPA |
Α-METHYL-L-DOPA |
APO-METHYLDOPA |
ALPHA-METHYLDIHYDROXYPHENYLALANINE |
ALDOMET® |
BAYPRESOL |
L-(A-MD) |
L(-)-BETA-(3,4-DIHYDROXYPHENYL)-ALPHA-METHYLALANINE |
ALDOMETIL |
L-(ALPHA-MD) |
ALPHA MEDOPA |
L-Α-METHYL-3,4-DIHYDROXYPHENYLALANINE |
DOPATEC |
3,4-DIHYDROXY-2-METHYLPHENYLALANINE (ACD/NAME 4.0) |
L-(-)-A-METHYL-A-METHYL-ALDOMIN |
HYPERPAX |
A-METHYL DOPA |
LEVO-3-(3,4-DIHYDROXYPHENYL)-2-METHYLALANINE |
PRESINOL |
DOPAMET® |
L-(-)-ALPHA-METHYL-ALPHA-METHYL-ALDOMIN |
ALDORIL D50 |
NOVO-MEDOPA TAB 250MG |
ANHYDROUS METHYLDOPA |
L-ALPHA-METHYL-3,4-DIHYDROXYPHENYLALANINE |
METHYLDOPA 250 TAB |
A-METHYL-L-3,4-DIHYDROXYPHENYLALANINE |
ALPHA-METHYL-BETA-(3,4-DIHYDROXYPHENYL)-L-ALANINE |
L-A-METHYL-(3, 4-DIHYDROXYPHENYL)ALANINE |
L-ALPHA-METHYL-(3, 4-DIHYDROXYPHENYL)ALANINE |
rxcui:6876 |
chemidplus:555-30-6 |
chembl:CHEMBL459 |
drugbank:00968 |
pubchem.compound:38853 |
rxcui:1545996 |
Year of Approval | 1962 |
Drug Class | antihypertensive agents |
FDA Approval | 1962 |
Drug Class | small molecule |
Drug Indications | Antihypertensive Agents |
agonist (activating) |
Trial Name | - |
Novel drug target | Established target |
Mechanism of Interaction | Adrenergic receptor alpha-2 agonist |
agonist (activating) |
Mechanism of Interaction | Adrenergic receptor alpha-2 agonist |
Direct Interaction | yes |
agonist (activating) |
Mechanism of Interaction | Adrenergic receptor alpha-2 agonist |
Direct Interaction | yes |
Drug Class | antihypertensive agents |
Year of Approval | 1962 |
Drug Indications | Antihypertensive Agents |
Drug Class | small molecule |
FDA Approval | 1962 |
CHEMBL459 | ChEMBL Drug ID |
D0BA6T | TTD Drug ID |